The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity.

The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity.
复制标题

DOI:
10.1016/j.ophtha.2011.05.013
复制
发表时间:
2011-12
期刊:
影响因子:
13.7
通讯作者:
Robin AL
Robin AL
中科院分区:
医学1区
文献类型:
--
作者:
Sleath B;Blalock S;Covert D;Stone JL;Skinner AC;Muir K;Robin AL

文献摘要

参考文献

被引文献

相似文献

本研究的目的是检查:(a)患者依从性和滴眼技术如何与视野缺损严重程度相关;(B)一般青光眼依从性自我效能和滴眼技术自我效能如何与视野缺损严重程度相关。在一个私人执业场所进行的横断面研究。因为青光眼而滴眼药水的病人。我们通过药物事件监测系统(MEMS)设备测量受试者对青光眼药物的依从性,并通过视频记录评估滴眼技术。我们使用10项量表测量一般青光眼药物依从性自我效能,使用6项量表测量滴眼技术自我效能。多因素Logistic回归分析。视野缺损严重度。根据MEMS帽,粘附率低于80%的患者明显更有可能具有更差的缺损严重度。一般青光眼药物依从性自我效能量表评分较低的患者也更可能有更严重的缺陷。滴眼剂使用技巧、滴眼剂使用技巧自我效能与视野缺损程度无显著相关。眼科护理提供者需要评估患者的依从性,并与依从性差的患者合作,以找到提高他们使用青光眼药物的能力和自我效能的方法。
The purpose of the study was to examine: (a) how patient adherence and eye drop technique were associated with visual field defect severity and (b) how general glaucoma adherence self-efficacy and eye drop technique self-efficacy were related to visual field defect severity. Cross-sectional study conducted at a single private practice site. Patients on eye drops for their glaucoma. We measured subjects’ adherence to glaucoma medications through Medication Events Monitoring System (MEMS) devices and assessed eye drop instillation technique by video-recording. We measured general glaucoma medication adherence self-efficacy using a 10-item scale and eye drop technique self-efficacy using a 6-item scale. Multivariable logistic regression was used to analyze the data. Visual field defect severity. Patients who were less than 80% adherent according to the MEMS caps were significantly more likely to have worse defect severity. Patients with lower scores on the general glaucoma medication adherence self-efficacy scale were also significantly more likely to have worse defect severity. Eye drop technique and eye drop technique self-efficacy were not significantly related to visual field defect severity. Eye care providers need to assess patient adherence and work with those patients with poor adherence to find ways to improve their ability and self-efficacy in using their glaucoma medications.
DOI: 10.1016/j.ophtha.2004.12.035
发表时间: 2005-06-01
期刊: OPHTHALMOLOGY
影响因子: 13.7
作者:
Olthoff, CMG;Schouten, JSAG;Webers, CAB
通讯作者: Webers, CAB
DOI: 10.1345/aph.1k671
发表时间: 2009-01-01
影响因子: 2.9
作者:
Martin, Bradley C.;Wiley-Exley, Elizabeth K.;Sleath, Betsy Lynn
通讯作者: Sleath, Betsy Lynn
DOI: 10.1016/j.ophtha.2005.10.034
发表时间: 2006-03-01
期刊: OPHTHALMOLOGY
影响因子: 13.7
作者:
Sleath, B;Robin, AL;Svarstad, B
通讯作者: Svarstad, B
DOI: 10.1016/j.ophtha.2009.01.021
发表时间: 2009-06-01
期刊: OPHTHALMOLOGY
影响因子: 13.7
作者:
Friedman, David S.;Okeke, Constance O.;Quigley, Harry A.
通讯作者: Quigley, Harry A.
DOI: 10.1001/archophthalmol.2009.96
发表时间: 2009-06-01
影响因子: --
作者:
Stone, Jennifer L.;Robin, Alan L.;Cagle, Gerald D.
通讯作者: Cagle, Gerald D.